NCT02208258View on ClinicalTrials.gov

Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool.

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Fecal Incontinence
Interventions
DEVICE

Consure 120 Stool Management System

Novel device designed to manage fecal incontinence in hospitalized bedridden patients with liquid to semi-formed stool.

Trial Locations (1)

92123

Sharp HealthCare, San Diego

Sponsors
All Listed Sponsors
lead

Consure Medical Pvt. Ltd.

INDUSTRY

NCT02208258 - Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool. | Biotech Hunter | Biotech Hunter